Cover Image
市場調查報告書

頭頸部癌:全球臨床實驗檢討

Head And Neck Carcinoma Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 298064
出版日期 內容資訊 英文 182 Pages
訂單完成後即時交付
價格
Back to Top
頭頸部癌:全球臨床實驗檢討 Head And Neck Carcinoma Global Clinical Trials Review, H1, 2014
出版日期: 2014年03月19日 內容資訊: 英文 182 Pages
簡介

本報告提供頭頸部癌的治療藥相關臨床實驗調查分析,提供臨床實驗數及被實驗人數,Phase別及各方面狀況,有潛力的企業,正在開發的治療藥的資訊,臨床實驗簡介等,為您概述為以下內容。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:腫瘤科臨床實驗中頭頸部癌的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:階段別

E7各國的臨床實驗:腫瘤科臨床實驗中頭頸部癌的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:階段別

各方面的臨床實驗

Phase別臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 參與頭頸部癌治療藥臨床實驗的主要企業

有前途藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Sanofi
    • AstraZeneca PLC
    • E. Merck KG
    • F. Hoffmann-La Roche Ltd.
    • Novartis AG
    • Eli Lilly and Company
    • Amgen Inc.
    • Pfizer Inc.
    • Celgene Corporation
    • C. H. Boehringer Sohn AG & Co. KG
  • 主要大學·研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • European Organization for Research and Treatment of Cancer
    • The University of Texas M. D. Anderson Cancer Center
    • Memorial Sloan Kettering Cancer Center
    • Radiation Therapy Oncology Group
    • University of Pittsburgh
    • Sidney Kimmel Comprehensive Cancer Center
    • The University of Chicago
    • Groupe Oncologie Radiotherapie Tete et Cou

主要的臨床簡介

附錄

圖表

目錄
Product Code: GDHC2031CTIDB

GlobalData's clinical trial report, "Head And Neck Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Head And Neck Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Head And Neck Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Head And Neck Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Head and Neck Carcinoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Head And Neck Carcinoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Head And Neck Carcinoma to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Head And Neck Carcinoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Head And Neck Carcinoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • E. Merck KG
      • Clinical Trial Overview of E. Merck KG
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Radiation Therapy Oncology Group
      • Clinical Trial Overview of Radiation Therapy Oncology Group
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • Sidney Kimmel Comprehensive Cancer Center
      • Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
      • The University of Chicago
      • Clinical Trial Overview of The University of Chicago
      • Groupe Oncologie Radiotherapie Tete et Cou
      • Clinical Trial Overview of Groupe Oncologie Radiotherapie Tete et Cou
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Head And Neck Carcinoma Therapeutics, Global, Clinical Trials by Region, 2014*
  • Head And Neck Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Head And Neck Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Head And Neck Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Head And Neck Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Head And Neck Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Head And Neck Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Head And Neck Carcinoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Head And Neck Carcinoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Head And Neck Carcinoma Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Head And Neck Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Head And Neck Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Head And Neck Carcinoma Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Head And Neck Carcinoma Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Head And Neck Carcinoma Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Head And Neck Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe Oncologie Radiotherapie Tete et Cou, 2014*

List of Figures

  • Head And Neck Carcinoma Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Head And Neck Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Head And Neck Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Head And Neck Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Head And Neck Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Head And Neck Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Head And Neck Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Head And Neck Carcinoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Head And Neck Carcinoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Head And Neck Carcinoma Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Head And Neck Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Head And Neck Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Head And Neck Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top